This two-part series will educate clinicians on how to reduce the potential for serious adverse outcomes resulting from inappropriate prescribing, misuse and abuse of extended release/long acting (ER/LA) opioid analgesics while ensuring continued access for patients with legitimate need for these drugs. These webinar recordings (synchronized PowerPoint and audio) are now available at no cost. Learners will be awarded 1.0 AMA PRA Category 1 Credits for each webinar. Use this high quality content as a reference when you need it or as part of staff training. Learners must complete parts 1 and 2 of this of this activity in order to be fully compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the FDA. Order your copy today.
Published in Brief: